Product Information

LOTEPREDNOL ETABONATE 0.5% DRP is a generic product labeled by Padagis US LLC, priced at $18.7123 per ML under NDC 00574413510. Its NADAC has been published 41 times since Feb 4, 2026.

FDA first approved this application on Jan 29, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LOTEPREDNOL ETABONATE 0.5% DRP

loteprednol etabonate
$18.7123per ML

Strength

5 mg/mL

Manufacturer

Padagis US LLC

NDC

00574413510

Classification

Generic

Dosage Form

SUSPENSION/ DROPS

Route

OPHTHALMIC

Effective Date

10/21/2026

Active Ingredients

LOTEPREDNOL ETABONATE

Approval Type

Generic (ANDA)

FDA Application

ANDA215204

FDA Approved

1/29/2025

TE Code

AB

On Market Since

12/15/2025

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for LOTEPREDNOL ETABONATE 0.5% DRP has been published 41 times since Feb 4, 2026, and over the history we have for it it has declined 9.6%. The table below summarizes its recorded NADAC range and movement.

Current price$18.7123 per ML
All-time high$22.0153 (Aug 12, 2026)
All-time low$18.7123 (Oct 21, 2026)
52-week high$22.0153
52-week low$18.7123
Median price$20.2219
Average price$20.5022
Largest weekly change-11.7% (Oct 21, 2026)
Weeks tracked41
Tracking sinceFeb 4, 2026

Price History

1W

0.0%

1M

-11.7%

3M

-14.2%

6M

-7.5%

1Y

N/A

3Y

N/A

5Y

N/A

All

-9.6%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 44% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LOTEPREDNOL ETABONATE 0.5% DRP?

The current National Average Drug Acquisition Cost (NADAC) for LOTEPREDNOL ETABONATE 0.5% DRP, manufactured by Padagis US LLC, is $18.7123 per ML (NDC 00574413510), effective Nov 11, 2026.

How has the price of LOTEPREDNOL ETABONATE 0.5% DRP changed over time?

Over the history we have for it, the NADAC for LOTEPREDNOL ETABONATE 0.5% DRP has declined 9.6%. It has been tracked across 41 weekly CMS publications since Feb 4, 2026.

What are the highest and lowest recorded NADAC prices for LOTEPREDNOL ETABONATE 0.5% DRP?

Since Feb 4, 2026, the NADAC for LOTEPREDNOL ETABONATE 0.5% DRP has ranged from a low of $18.7123 (Oct 21, 2026) to a high of $22.0153 (Aug 12, 2026), with a median of $20.2219 per ML.

Are there cheaper alternatives to LOTEPREDNOL ETABONATE 0.5% DRP?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LOTEPREDNOL ETABONATE 0.5% DRP, is $10.4368 per ML — about 44% below LOTEPREDNOL ETABONATE 0.5% DRP.

Who manufactures LOTEPREDNOL ETABONATE 0.5% DRP?

LOTEPREDNOL ETABONATE 0.5% DRP (NDC 00574413510) is labeled by Padagis US LLC, and CMS classifies it as a generic product.